Qin Xu

Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1–Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial

Qin Xu, Junjie Wang, Yang Sun et al. · Journal of Clinical Oncology · 2022 · 145 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A Novel Selective Progesterone Receptor Modulator Asoprisnil (J867) Inhibits Proliferation and Induces Apoptosis in Cultured Human Uterine Leiomyoma Cells in the Absence of Comparable Effects on Myometrial Cells

Wei Chen, Noriyuki Ohara, Jiayin Wang et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 92 citations

Medicine, Endocrinology, Pharmacology +17

Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells

Qin Xu · Human Reproduction · 2006 · 91 citations

Life Sciences, Endocrinology, Molecular Biology +14

Progesterone Receptor Modulator CDB-2914 Down-Regulates Proliferative Cell Nuclear Antigen and Bcl-2 Protein Expression and Up-Regulates Caspase-3 and Poly(Adenosine 5′-Diphosphate-ribose) Polymerase Expression in Cultured Human Uterine Leiomyoma Cells

Qin Xu, Shigeki Takekida, Noriyuki Ohara et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 87 citations · Full text

Life Sciences, Cell Biology, Endocrinology +16

Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis

Bin Yang, Xiong Li, Wei Zhang et al. · Cell Reports Medicine · 2022 · 79 citations · Full text

Medicine, Immunology, Oncology +17